ReviewActa pharmacologica Sinica2026

Beyond conventional therapies: the evolution of targeted agents and immunotherapies in triple-negative breast cancer.

Hui-Fang Cheng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.